For Enrollment in the Cystic Fibrosis Mutation Analysis Program
What is the Mutation Analysis Program (MAP)?
The MAP is a valuable program that provides free genotyping and follow-up testing as needed for people with cystic fibrosis.
back to top
What are the eligibility requirements for participating in the MAP?
Patients must have a diagnosis of cystic fibrosis and have not yet had genetic testing to determine their CF mutations or have been tested previously but still have one or more unknown mutations. There are no income or insurance requirements.
back to top
What are the benefits of participating in the MAP?
The MAP will help providers and patients make informed decisions about their treatment options.
back to top
What expenses does the Cystic Fibrosis Foundation (CFF) cover?
The CFF will cover the cost of the genotyping. However, the patient or CF care center is responsible for the cost of the blood sample, and shipping and postage for mailing the sample to the lab.
back to top
Where can my CF patient go to get a blood sample taken?
Patients may get their blood drawn at the designated care center lab, if available. Otherwise, it is at the provider’s and patient’s discretion to utilize a lab that is most convenient.
back to top
How long will the CF Foundation offer this program?
The demand and need for the MAP program will be evaluated on an ongoing basis. Currently, there is no deadline for the program.
back to top
Can a patient participate in this program multiple times?
No. Patients may only participate once.
back to top
How long will it take for the care center to receive an authorization number for each approved patient?
Forms will be approved on a first-come, first-served basis. The accuracy and completion of the enrollment form and program volume will determine the time it takes to receive an authorization number.
back to top
What types of testing are offered?
All CF patients enrolled in the MAP will receive genotyping for CFTR mutations. Further testing will be conducted if one or more mutations remain unknown after genotyping.
back to top
Will the patient’s name and test results be released to the public?
No, patients’ names and corresponding test results will not be released to the public. Test results will be released to the CF Foundation and the referring doctor or CF care center.
back to top
When can providers expect test results for their patients?
In order to allocate funds in the most efficient way, testing occurs in batches. It can take up to 60 days to receive genotyping results, and additional time if further testing is needed.
back to top
